Described herein are pharmaceutical packaging systems which stop oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medicines, this sort of units together with a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely low permeability to oxygen and